Notably, only two genes including regulator of G-protein signaling 1 (RGS1) and CD82 were classified into the Same type for all four MPLCs patients with higher expression in tumor tissues than normal tissues (Fig. 7a). The gene discussed is CD82; the disease is neoplasm.